7h
Zacks Investment Research on MSNRecursion Pharma Down 37% in a Month: Buy, Sell or Hold the Stock?Recursion Pharma RXRX shares have plunged 37.1% in the past month compared with the industry’s 1.4% decline. The company has also underperformed in the sector and the S&P 500 during the same time ...
During afternoon trading, there was significant selling pressure on Shukra Pharmaceuticals stock, which had a market value of Rs 1.08KCr. As a result, the stock was put at a 2% lower circuit limit of ...
8h
Zacks Investment Research on MSNAscendis Pharma (ASND) Soars 10.4%: Is Further Upside Left in the Stock?Ascendis Pharma A/S (ASND) shares rallied 10.4% in the last trading session to close at $168.84. This move can be attributable to notable volume with a higher number of shares being traded than in a ...
Novo Nordisk is launching a new direct-to-patient online pharmacy called NovoCare, which will offer Wegovy at a discounted price of $499 per month, less than half of its listed price. This offer ...
We sifted through stock screeners, online rankings, and ETFs to compile a list of 25 pharma stocks. We then selected the top ...
Vincerx Pharma shares jumped Tuesday morning after the company said that it has entered into an agreement to combine with privately held AI computing infrastructure company Global Digital Holdings.
Checkpoint Therapeutics is being acquired by Sun Pharmaceutical for $4.10 per share. Learn why CKPT stockholders could earn ...
Further, it sells the products to specialty pharmacy and specialty distributors in the United States, as well as retail pharmacies, hospitals, and clinics. Additionally, the company has ...
Sun Pharma is a top-ranked Indian pharmaceutical firm. The company’s stock has been continuously in the news lately for ...
Explore Zentalis Pharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ZNTL. FDA Removes Partial Hold On Zentalis Pharmaceuticals' Azenosertib Studies ...
Fear, uncertainty, and doubt have become the norm in early 2025 with rising stock market volatility. David Jagielski (Eli Lilly): A top pharma stock that I wouldn't hesitate to buy right now and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results